Hennion & Walsh Asset Management, Inc.

Position in PHAT — Phathom Pharmaceuticals, Inc.

CIK 1861642 Parsippany, NJ

Position in PHAT

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$3,550,966

+$1,929,662 QoQ

Shares Held

327,278

+124.3% QoQ

Ownership

0.410%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

of 20 holders

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Hennion & Walsh Asset Management, Inc. holds $200,308,891 across 60 Biotechnology names. PHAT ranks #24 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	48,019	$11,571,138
2	CELC	Celcuity Inc.	100,368	$10,500,500
3	URGN	UroGen Pharma Ltd.	276,696	$10,182,412
4	TVTX	Travere Therapeutics, Inc.	171,470	$9,741,210
5	SNDX	Syndax Pharmaceuticals Inc	342,883	$7,495,422
6	QURE	uniQure N.V.	142,113	$6,545,724
7	KURA	Kura Oncology, Inc.	568,845	$6,240,229
8	ARDX	Ardelyx, Inc.	1,211,690	$6,179,619

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,550,966	327,278	+124.3%	Shares	Sole	2026-07-08
2026-03-31	$1,621,304	145,932	+26.9%	Shares	Sole	2026-05-13
2025-12-31	$1,907,534	114,981	+134.7%	Shares	Sole	2026-01-14
2023-09-30	$507,995	48,987	-16.5%	Shares	Sole	2023-10-27
2023-06-30	$839,982	58,658	+1.1%	Shares	Sole	2023-08-09
2023-03-31	$414,419	58,042	-2.3%	Shares	Sole	2023-04-20
2022-12-31	$666,535	59,406	+8.7%	Shares	Sole	2023-01-12
2022-09-30	$605,754	54,671	-3.2%	Shares	Sole	2022-11-14
2022-06-30	$476,893	56,504	+10.7%	Shares	Sole	2022-07-19
2022-03-31	$694,817	51,052	+65.2%	Shares	Sole	2022-04-26
2021-12-31	$607,684	30,894	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.